Clinical Trial Details
— Status: Completed
Administrative data
NCT number |
NCT04485312 |
Other study ID # |
abcxyz |
Secondary ID |
|
Status |
Completed |
Phase |
N/A
|
First received |
|
Last updated |
|
Start date |
July 15, 2020 |
Est. completion date |
July 15, 2021 |
Study information
Verified date |
August 2021 |
Source |
Cairo University |
Contact |
n/a |
Is FDA regulated |
No |
Health authority |
|
Study type |
Interventional
|
Clinical Trial Summary
Adolescent Special need individuals are most need of easy forms of antibacterial agents, so
in this study, using chemotherapeutic agents like the newly introduced varnish containing
chlorhexidine seems to be a quite promising tool for local delivery to patients with special
needs . Chlorhexidine is a wide spectrum very effective bactericidal used for years against
the oral flora while fluorides are well known with their antibacterial ability. This may be
an excellent way to reduce the risk assessment in adolescent special needs patients.
Description:
Participants will be divided into two groups according to the tested regimen, where (A1)
represents participants exposed to risk based conventional protocol, (A2) represents
participants exposed to chlorhexidine containing varnish and risk based conventional
preventive protocol. The study will be carried over a period of 10 months (one academic
year), the study will be divided into three phases Phase I: Information of the Cariogram
parameters (caries experience, diet content, diet frequency, plaque amount, mutans
streptococci, fluoride program, saliva secretion and saliva buffer capacity) will be
collected, which will be used to generate the individual caries profile, based on which the
participants will be divided into 2 risks groups. Phase II: Risk based preventive program
will be implemented including the restorative part. Phase III: At the end of 10 months,
caries profile will be generated again